National Healthcare Properties, Inc. (NHPAP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 35M 70M 105M Q3 '21: 82M Q4 '21: 82.8M Q1 '22: 83.7M Q2 '22: 83.8M Q3 '22: 83.5M Q4 '22: 84.9M Q1 '23: 87.4M Q2 '23: 86.1M Q3 '23: 85.7M Q4 '23: 86.8M Q1 '24: 88.3M Q2 '24: 88.8M Q3 '24: 88.9M Q4 '24: 87.7M Q1 '25: 86.4M Q2 '25: 85.3M Q3 '25: 86M Q4 '25: 84.5M Q1 '26: 86.3M Q2 '26: 87.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 15M 30M 45M Q3 '21: 30.8M Q4 '21: 29.1M Q1 '22: 30.6M Q2 '22: 31.2M Q3 '22: 32.3M Q4 '22: 28.3M Q1 '23: 33.5M Q2 '23: 32.5M Q3 '23: 31.4M Q4 '23: 30.8M Q1 '24: 33.2M Q2 '24: 33.8M Q3 '24: 32.5M Q4 '24: 32.8M Q1 '25: 28.6M Q2 '25: 31.2M Q3 '25: 32.2M Q4 '25: 31.5M Q1 '26: 33.4M Q2 '26: 33.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '21: -28.6M Q4 '21: -7.6M Q1 '22: -12.6M Q2 '22: -5.9M Q3 '22: -8.3M Q4 '22: -4.7M Q1 '23: 1.9M Q2 '23: 813K Q3 '23: -912K Q4 '23: -6.6M Q1 '24: -1.1M Q2 '24: -100.4M Q3 '24: -20.9M Q4 '24: -1.1M Q1 '25: 13M Q2 '25: -5.5M Q3 '25: 2.4M Q4 '25: -6.6M Q1 '26: 10.1M Q2 '26: 5.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-120M -80M -40M 0 40M 80M 120M Q3 '21: -40.5M Q4 '21: -19.4M Q1 '22: -23.4M Q2 '22: -17.6M Q3 '22: -19.9M Q4 '22: -18.7M Q1 '23: -14.1M Q2 '23: -17.3M Q3 '23: -16.1M Q4 '23: -24.9M Q1 '24: -15.6M Q2 '24: -116.9M Q3 '24: -40.8M Q4 '24: -17M Q1 '25: -1.5M Q2 '25: -20.8M Q3 '25: -12.5M Q4 '25: -22.8M Q1 '26: -4.3M Q2 '26: -5.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '21: 8.4M Q4 '21: 12.9M Q1 '22: 5.9M Q2 '22: 7.9M Q3 '22: 7.4M Q4 '22: 7.2M Q1 '23: 5M Q2 '23: 5.7M Q3 '23: 5.7M Q4 '23: 5.3M Q1 '24: 2.5M Q2 '24: 6.4M Q3 '24: -95.2M Q4 '24: 6.5M Q1 '25: -21.2M Q2 '25: 8.1M Q3 '25: 10.2M Q4 '25: 10M Q1 '26: 9M Q2 '26: 21.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '21: 4.1M Q4 '21: 5.3M Q1 '22: 2.6M Q2 '22: 2.1M Q3 '22: -274K Q4 '22: -4.1M Q1 '23: 1.4M Q2 '23: 182K Q3 '23: 823K Q4 '23: -3.1M Q1 '24: -2.6M Q2 '24: 393K Q3 '24: -100.5M Q4 '24: 946K Q1 '25: -26.9M Q2 '25: 1.4M Q3 '25: 5.6M Q4 '25: -1.8M Q1 '26: 3.7M Q2 '26: 16.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q4 '14: 83.4M Q2 '20: 97.3M Q3 '20: 99M Q1 '21: 101.9M Q2 '21: 103.4M Q3 '21: 104.9M Q1 '22: 108M Q2 '22: 109.7M Q3 '22: 111.4M Q1 '23: 113.1M Q2 '23: 113.1M Q3 '23: 28.3M Q1 '24: 28.3M Q2 '24: 28.3M Q3 '24: 28.3M Q1 '25: 28.3M Q2 '25: 28.3M Q3 '25: 28.3M Q1 '26: 28.3M Q2 '26: 61.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q3 '20: -1.11 Q4 '20: -0.75 Q1 '21: -0.61 Q2 '21: -0.53 Q3 '21: -0.82 Q4 '21: -0.82 Q1 '22: -0.95 Q2 '22: -0.99 Q3 '22: -0.80 Q4 '22: -3.31 Q1 '23: -3.21 Q2 '23: -3.20 Q3 '23: -3.68 Q4 '23: -2.01 Q1 '24: -2.53 Q2 '24: -6.59 Q3 '24: -7.46 Q4 '24: -7.19 Q1 '26: -2.60 Q2 '26: -1.88 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.